Showing results (251-260 of 271) with videos related to

Sort By:
Pageof 28
Anti-Cancer Drugs|April 11, 2013
Pegylated filgrastim is comparable with filgrastim as support for commonly used chemotherapy regimens: a multicenter, randomized, crossover phase 3 studyYuan-Kai Shi, Qiang Chen, Yun-Zhong Zhu, et al.
Journal of Geriatric Cardiology : JGC|March 14, 2020
Beneficial effects of moderate to vigorous physical activity on cardiovascular disease among Chinese adultsQiong Liu, Fang-Chao Liu, Ke-Yong Huang, et al.
Journal of Geriatric Cardiology : JGC|December 15, 2023
Lifestyle improvement and the reduced risk of cardiovascular disease: the China-PAR projectYing-Ying Jiang, Fang-Chao Liu, Chong Shen, et al.
Journal of Geriatric Cardiology : JGC|April 28, 2021
Effects of the total physical activity and its changes on incidence, progression, and remission of hypertensionCan Cai, Fang-Chao Liu, Jian-Xin Li, et al.
Annals of Translational Medicine|August 5, 2021
Earlier diagnosis improves COVID-19 prognosis: a nationwide retrospective cohort analysisYi-Jun Chen, Wen-Hua Jian, Zhen-Yu Liang, et al.
Microbiology Spectrum|September 6, 2024
Clinical and pathogen features of COVID-19-associated infections during an Omicron strain outbreak in Guangzhou, ChinaLin-Ling Cheng, Zheng-Tu Li, Hong-Kai Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non-Small Cell Lung Cancer: a Multicenter Phase I/II StudyQing Zhou, Lin Wu, Pei Hu, et al.
The Journal of Clinical Investigation|August 28, 2020
Vaccine targeting SIVmac251 protease cleavage sites protects macaques against vaginal infectionHongzhao Li, Robert W Omange, Binhua Liang, et al.
Chinese Journal of Integrative Medicine|June 20, 2022
Analysis of Chinese Medical Syndrome Features of Ischemic Stroke Based on Similarity of Symptoms SubgroupXiao-Qing Liu, Run-Shun Zhang, Xue-Zhong Zhou, et al.
Thoracic Cancer|September 19, 2017
Long-term results of a randomized, double-blind, and placebo-controlled phase III trial: Endostar (rh-endostatin) versus placebo in combination with vinorelbine and cisplatin in advanced non-small cell lung cancerYan Sun, Jin Wan Wang, Yong Yu Liu, et al.
Pageof 28